The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, non-comparative, phase II multicentric trial on short-term darolutamide (ODM-201) concomitant to radiation therapy for patients with unfavorable intermediate-risk prostate cancer: DARIUS (AFU-GETUG P15).
 
Guilhem Roubaud
No Relationships to Disclose
 
Carine A. Bellera
No Relationships to Disclose
 
Sabrina Sellan-Albert
No Relationships to Disclose
 
Mathilde Cabart
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Diego Teyssonneau
No Relationships to Disclose
 
Nam-Son Vuong
No Relationships to Disclose
 
Ludivine Poignie
No Relationships to Disclose
 
Nicolas Benziane-Ouaritini
No Relationships to Disclose
 
Paul Sargos
No Relationships to Disclose